Borregaard

Earnings Release • Apr 30, 2025

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter

Borregaard ASA: EBITDA1 of NOK 511 million in the 1st quarter

Borregaard's operating revenues increased to NOK 2,036 million (NOK 1,975

million)(2) in the 1(st) quarter of 2025. EBITDA(1) reached NOK 511 million (NOK

442 million). The result in BioSolutions increased, BioMaterials had a result in

line with the corresponding quarter last year and Fine Chemicals had a lower

result.

Strong sales to agriculture were the main reason for the all-time high result in

BioSolutions. For BioMaterials, higher sales prices were offset by lower sales

volume, increased wood costs, and cost increases in general. Lower sales prices

for bioethanol were the main reason for the weaker result in Fine Chemicals. The

net currency effects were positive.

Profit before tax was NOK 319 million (NOK 261 million). Earnings per share were

NOK 2.52 (NOK 2.01).

- We are pleased to report an all-time high result for BioSolutions. Our

specialisation strategy has demonstrated resilience amid challenging

macroeconomic conditions and will remain the key driver of our future success,

says President and CEO Per A. Sørlie.

Contacts:

Director Investor Relations, Knut-Harald Bakke, +47 905 79 164

Director Communications, Tone Horvei Bredal, +47 924 67 711

1. Operating profit before depreciation, amortisation and other income and

expenses

2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU

Market Abuse Regulation and is subject to the disclosure requirements pursuant

to Section 5 - 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor

Relations Officer at Borregaard ASA, on 30 April 2025 at 07:00 CEST.